Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials.

Respir Res · 2020 · PMC6990488 · PMID 32000772

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, these did not reach statistical significance.

also in 111,027 other papers

a numerical trendno p-value reported

There was a numerical trend towards a reduction in deterioration from baseline with nintedanib compared with placebo for some additional PROs, including in some subgroups with less-advanced disease.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.